Analyst Ratings for Theravance Biopharma (TBPH) [Sells]
TBPH Rating Summary
TBPH Price Target Summary
- Highest: $21.00 (BTIG)
- Lowest: $10.00 (TD Cowen)
- Average: $15.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$15.50 (+68.1%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 53%
Avg. $ Target:
$15.50 (+68.1%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 53%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/25/2021 | Morgan Stanley » Updated 7/25/2022 |
Vikram Purohit | Downgrade | Underweight (Overweight) |
10.00 (11.00) |
14.17 (9.22) |
-34.93% | Details |
| 1/27/2017 | Empire Asset | N/A | New Coverage | Sell (N/A) |
16.00 (N/A) |
28.90 (9.22) |
-68.1% | Details |
 |
||||||||
